Clinical Trials Directory

Trials / Conditions / Stage IV Uterine Sarcoma

Stage IV Uterine Sarcoma

11 registered clinical trials studyying Stage IV Uterine Sarcoma.

StatusTrialSponsorPhase
CompletedPatient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Pa
NCT01098630
Gynecologic Oncology Group—
CompletedTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
University of Southern CaliforniaPhase 1
CompletedVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedTherapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
NCT01553539
Wake Forest University Health SciencesPhase 2
CompletedStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan
NCT01079832
Case Comprehensive Cancer CenterPhase 2
CompletedAZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360
National Cancer Institute (NCI)Phase 2
CompletedZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissu
NCT00390234
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
NCT00245102
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
NCT00238121
National Cancer Institute (NCI)Phase 2
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
Completed17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymph
NCT00004241
National Cancer Institute (NCI)Phase 1